# Evaluataion of NOAC Levels in Acute Stroke

> **NCT06144866** · — · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 1000 (estimated)

## Conditions studied

- Ischemic Stroke
- Anticoagulant Adverse Reaction

## Interventions

- **DRUG:** Dabigatran, rivaroxaban, apixaban, edoxaban

## Key facts

- **NCT ID:** NCT06144866
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-01
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2023-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06144866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06144866, "Evaluataion of NOAC Levels in Acute Stroke". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06144866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*